Table 3. Reduced-intensity allogeneic stem cell transplantation for myelofibrosis.
| Author | N | Median age (years) | 1-year TRM, % | 5-year overall survival, % | 5-year progression-free survival, % |
|---|---|---|---|---|---|
| Kroger et al.29 | 103 | 53 | 16 | 67 | 51 |
| Merrup et al.30 | 27 | 51 | 10 (RIC), 30 (ablative) | 90 (RIC), 55 (ablative) | — |
| Ballen et al.15 | 60 | 47 (myeloablative and RIC) | 15 | — | 39 |
| Bacigalupo et al.37 | 46 | 51 | 24 | 45 | 43 |
| Alchalby et al.42 | 162 | 57 | 22 | 62 | 46 |
| Stewart et al.32 | 51 | 54 | 32 (RIC), 41 (ablative; 3 years) | 31 (RIC), 44 (ablative) | 24 (RIC), 44 (ablative) |
Abbreviations: RIC, reduced-intensity conditioning; TRM, transplant-related mortality.